| Cat. No. | Product Name | Field of Application | Chemical Structure |
|---|---|---|---|
| A253 | Centocor patent anti-IL-25 Biosimilar（Anti-IL-25 Reference Antibody） Featured |
|
|
| A254 | Dacliximab Biosimilar（Anti-IL-2Ra / CD25 Reference Antibody） Featured | Daclizumab (Zenapax) is a humanized, monoclonal antibody that blocks CD25 (α-subunit of the high-affinity interleukin-2 receptor (IL-2R-HA)). Daclizumab (Zenapax) reversibly binds to CD25and prevents the interaction of IL-2 with the IL-2R-HA. Daclizumab (Zenapax) can be used for multiple sclerosis research. |
.png)
|
| A255 | Camidanlumab Biosimilar（Anti-IL-2Ra / CD25 Reference Antibody） Featured | Camidanlumab (HuMax-TAC) is a CD25 monoclonal antibody. Camidanlumab targets the cell-surface antigen CD25, which is over-expressed on a variety of hematological tumors and shows limited expression on normal tissues. Camidanlumab can be used for synthesis of antibody agent conjugates (ADCs) to research several diseases including lymphoma and leukemia. |
.png)
|
| A256 | Singapore ASTR patent anti-IL-2R beta / IL-2R gamma Biosimilar（Anti-IL-2Rb / CD122 Reference Antibody） Featured |
|
|
| A257 | Nemolizumab Biosimilar（Anti-IL-31Ra Reference Antibody） Featured | Nemolizumab (CIM331) is a humanized antihuman interleukin-31 receptor A monoclonal antibody that inhibits the binding of interleukin-31 (IL-31) to its receptor and subsequent signal transduction. Nemolizumab can used be in research of atopic dermatitis (AD). |
.png)
|
| A258 | Itepekimab Biosimilar（Anti-IL-33 Reference Antibody） Featured | Itepekimab (REGN-3500) is an IgG4 monoclonal antibody against IL-33. Itepekimab reduced airway inflammation and related tissue damage in preliminary clinical studies. Itepekimab has potential effects in asthma, chronic obstructive pulmonary disease (COPD), and atopic dermatitis (AD). |
|
| A259 | Tozorakimab Biosimilar（Anti-IL-33 Reference Antibody） Featured | Tozorakimab (MEDI-3506) is a human immunoglobulin G1 monoclonal antibody targeting interleukin-33. Tozorakimab reduces inflammation and epithelial dysfunction. Tozorakimab can be used to research chronic obstructive pulmonary disease. |
|
| A260 | Torudokimab Biosimilar（Anti-IL-33 Reference Antibody） Featured |
|
|
| A261 | Etokimab Biosimilar（Anti-IL-33 Reference Antibody） Featured | Etokimab (Antibody ANB 020) is a humanized monoclonal antibody that targets IL-33. Etokimab can be used for the research of atopic dermatitis. |
|
| A262 | Talacotuzumab Biosimilar（Anti-IL-3Ra / CD123 Reference Antibody） Featured | Talacotuzumab (JNJ 56022473; CSL 362) is an IgG1-type fully humanized, CD123-neutralizing monoclonal antibody containing a modified Fc structure. Talacotuzumab has KDs of 0.43 nM, 188 nM, 46 nM, 16.8 nM for CD123, CD32b/c, CD16-158F, CD16-158V, respectively. Talacotuzumab inhibits IL-3 binding to CD123, antagonizing IL-3 signaling in target cells. Talacotuzumab has mutated the Fc region to increase affinity for CD16 (FcγRIIIa), thereby enhancing antibody-dependent cell-mediated cytotoxicity (ADCC). Talacotuzumab is highly effective in vivo reducing leukemic cell growth in acute myeloid leukemia (AML) xenograft mouse models. |
|
| A263 | SNG-CD123A Biosimilar(Anti-IL-3Ra / CD123 Reference Antibody) Featured |
|
|
| A264 | MEDI2045 Biosimilar(Anti-IL-4Ra / CD124 Reference Antibody) Featured |
|
|
| A265 | Depemokimab Biosimilar(Anti-IL-5 Reference Antibody) Featured | Depemokimab (GSK-3511294) is a long-acting anti-IL-15 monoclonal antibody. Depemokimab can be used for research of asthma. |
|
| A266 | Abgenix anti-IL-5 Biosimilar(Anti-IL-5 Reference Antibody) Featured |
|
|
| DC66871 | 1-Propanone, 1-(3-chlorophenyl)-3-(methylthio)- Featured |
|
|
| DC66872 | 4-Hepten-3-one, 1,7-bis(4-hydroxy-3-methoxyphenyl)- Featured |
|
|
| DC66873 | 4-Hepten-3-one, 1,7-bis(4-hydroxy-3-methoxyphenyl)-, (4Z)- Featured |
|
|
| DC66874 | WAY-311207-A Featured |
|
|
| DC66875 | CDK1-IN-2 Featured | CDK1-IN-2 is a CDK1 inhibitor (IC50: 5.8 μM). |
|
| DC66876 | Rpn11-IN-1 Featured |
|
|
| DC66877 | New Red Featured | New Red is a color additive that can be used to dye flour as well as meat products. |
|
| DC66878 | 9-(dimethylamino)-3-(4-ethylphenyl)pyrido[1,2]thieno[3,4-d]pyrimidin-4-one Featured |
|
|
| DC66879 | ST-14328 Featured |
|
|
| DC66880 | 8-Quinolinecarboxamide, 1,2-dihydro-2,2,4-trimethyl-N-[(1S,2E)-3-(methylsulfonyl)-1-(phenylmethyl)-2-propen-1-yl]- Featured |
|
|
| DC66881 | WNK1-IN-1 Featured | WNK1-IN-1 is a selective inhibitor of WNK1 with an IC50 value of 1.6 μM. WNK1-IN-1 inhibits OSR1 phosphorylation with an IC50 value of 4.3 μM. WNK1-IN-1 can be used for the research of blood pressure regulation and cancer. |
|
| DC66882 | sRANKL inhibitor S3-15 Featured | sRANKL inhibitor S3-15 is a highly potent, orally active inhibitor of soluble RANKL, selectively interrupt soluble RANKL-RANK interaction and without interfering with the membrane RANKL-RANK interaction, shows potent osteoclast inhibition effect with IC50 of 0.19 uM in vitro. |
|
| DC66883 | Halosulfuron Featured |
|
|
| DC66884 | Clenpenterol Hydrochloride Featured |
|
|
| DC66885 | Vitamin K5 hydrochloride Featured | Vitamin K5 (hydrochloride) is a naphthoquinones compound, shows trichomonacidal activity in vitro. Vitamin K5(hydrochloride) can be used for the research of anti-infection. |
|
| DC66886 | 7α-Hydroxycholesterol Featured | 7α-Hydroxycholesterol is a cholesterol oxide and is formed by both enzymatic and non-enzymatic oxidation. 7α-Hydroxycholesterol can be used as a biomarker for lipid peroxidation. |
|
